NUTSHELL Therapeutics
Latest round
- Series C
Last raised
- Sep 2026
Total raised
- $60M
Investors
- 11
About NUTSHELL Therapeutics
, trading as NUTSHELL Therapeutics, is a biotech company that focuses on the research and development of allosteric drug. NUTSHELL Therapeutics has built the AlloStar™ drug discovery platform and AlloMatrix protein conformation database to identify hidden allosteric binding sites and design small-molecule drugs, while advancing a portfolio of nearly 20 internally developed programs targeting oncology, CNS, autoimmune, and metabolic diseases. The company's revenue is generated by providing allosteric drug.+ physical computing platform and the development of core pipelines, helping to bring high-quality new drugs empowered by AI technology to the world.
Who invested in NUTSHELL Therapeutics
11 investors across 3 rounds
See all investors in NUTSHELL Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NUTSHELL Therapeutics
Who invested in NUTSHELL Therapeutics?
NUTSHELL Therapeutics has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NUTSHELL Therapeutics raised?
NUTSHELL Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did NUTSHELL Therapeutics last raise money?
NUTSHELL Therapeutics's most recent round on record is a Series C, in Sep 2026.
What does NUTSHELL Therapeutics do?
, trading as NUTSHELL Therapeutics, is a biotech company that focuses on the research and development of allosteric drug.
Where is NUTSHELL Therapeutics headquartered?
NUTSHELL Therapeutics is headquartered in Shanghai, China.
Which VCs invest in companies like NUTSHELL Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at NUTSHELL Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like NUTSHELL Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.